2-(Quinazolin-4-ylamino)-[1,4]benzoquinones as covalent-binding, irreversible inhibitors of the kinase domain of vascular endothelial growth factor receptor-2.
Wissner A, Floyd MB, Johnson BD, Fraser H, Ingalls C, Nittoli T, Dushin RG, Discafani C, Nilakantan R, Marini J, Ravi M, Cheung K, Tan X, Musto S, Annable T, Siegel MM, Loganzo F.
Wissner A, et al. Among authors: siegel mm.
J Med Chem. 2005 Dec 1;48(24):7560-81. doi: 10.1021/jm050559f.
J Med Chem. 2005.
PMID: 16302797